Clinical Drug Experience Knowledgebase

Breast Neoplasms (Phase 2)

Breast Neoplasms, Male (Phase 2)

Burkitt Lymphoma (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Endometrial Neoplasms (Phase 1)

Esophageal Neoplasms (Phase 2)

Gallbladder Neoplasms (Phase 2)

Hamartoma (Phase 2)

Hodgkin Disease (Phase 1)

Intraocular Lymphoma (Phase 1)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 1)

Leukemia, Eosinophilic, Acute (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 1)

Lymphoma, B-Cell, Marginal Zone (Phase 1)

Lymphoma, Follicular (Phase 1)

Lymphoma, Large B-Cell, Diffuse (Phase 1)

Lymphoma, Large-Cell, Anaplastic (Phase 1)

Lymphoma, Large-Cell, Immunoblastic (Phase 1)

Lymphoma, Mantle-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 1)

Lymphoma, T-Cell (Phase 1)

Myelodysplastic-Myeloproliferative Diseases (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Myeloproliferative Disorders (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Polycythemia Vera (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Sezary Syndrome (Phase 1)

Thrombocythemia, Essential (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Vaginal Neoplasms (Phase 2)

Vulvar Neoplasms (Phase 1)

Waldenstrom Macroglobulinemia (Phase 1)